Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07182851Recruiting

Prevalence of Pain in Mechanically Ventilated Patients in Intensive Care Units

Role: collaborator

NCT04746118Not ApplicableUnknown

Diet and Other Non Pharmacological Interventions to Reduce Cardiovascular Risk in Hypertensive Patients

Role: lead

NCT03183752Not ApplicableCompleted

Insulin Resistance and Metformin Use on Volume of Benign Thyroid Nodules

Role: lead

NCT01841775Phase 4Completed

Interferon α 2b Pharmacovigilance Study

Role: collaborator

All 4 trials loaded